Literature DB >> 6183036

Treatment of hypertension with angiotensin converting enzyme inhibitors.

C I Johnston, B P McGrath, P G Matthews, B Jackson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6183036

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol Suppl        ISSN： 0143-9294


× No keyword cloud information.
  6 in total

1.  Angiotensin-converting enzyme inhibitors in the treatment of hypertension.

Authors:  C I Johnston; L Arnolda; M Hiwatari
Journal:  Drugs       Date:  1984-03       Impact factor: 9.546

2.  Enalapril (MK421) activation in man: importance of liver status.

Authors:  I Larmour; B Jackson; R Cubela; C I Johnston
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

3.  Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension.

Authors:  C I Johnston; B J Jackson; I Larmour; R Cubella; D Casley
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

4.  The pharmacokinetics of captopril and captopril disulfide conjugates in uraemic patients on maintenance dialysis: comparison with patients with normal renal function.

Authors:  O H Drummer; B S Workman; P J Miach; B Jarrott; W J Louis
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.

Authors:  R A Sánchez; E Marcó; H B Gilbert; P Raffaele; M Brito; M Giménez; L I Moledo
Journal:  Drugs       Date:  1985       Impact factor: 9.546

6.  Captopril-induced bilateral parotid and submandibular sialadenitis.

Authors:  Rafael Mariano Gislon Da Silva
Journal:  Eur J Clin Pharmacol       Date:  2004-07-06       Impact factor: 3.064
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.